RXi Pharmaceuticals Corp. (RXII) Cuts Q2 Loss to 4c/Share
Tweet
Share
E-mailGet Alerts RXII Hot Sheet
Join SI Premium – FREE
RXi Pharmaceuticals Corp. (Nasdaq: RXII) reported Q2 loss of ($0.04), versus a loss of ($0.12) reported in the same period last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
- ConAgra Brands (CAG) Tops Q1 EPS by 13c, Beats on Revenue; Offers FY27 EPS Guidance
- Precision Optics Corporation, Inc. (POCI) Reports Q4 Loss of $0.01
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
